A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology. 2012

Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

A 26-year-old female who had had a hydatidiform mole at 20 years of age showed high levels of serum human chorionic gonadotropin. Because pelvic ultrasound did not show any gestational sac in her uterus, she was suspected to have had an extrauterine pregnancy and a spontaneous abortion. About 6 months later, a pulmonary nodule in the patient's right upper lung field was found on a routine chest X-ray film. Contrast- enhanced CT scans revealed a solitary lobulated nodule 2.0 × 1.3 × 3.0 cm in diameter in the S2 segment of the right lung. CT suggested a vessel malformation. Positron emission tomography using 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG-PET) was performed and showed weak FDG accumulation (SUVmax = 2.0) in the nodule, which did not positively indicate malignancy. Because a follow-up CT showed a rapid increase in the size of the nodule, partial resection of S2 segment in the right upper lobe was performed. The histopathological diagnosis was a metastasis from choriocarcinoma. The tumor consisted largely of necrosis and hemorrhage, and it was considered to be a major cause of the unusual FDG-PET and CT findings.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014057 Tomography, X-Ray Computed Tomography using x-ray transmission and a computer algorithm to reconstruct the image. CAT Scan, X-Ray,CT Scan, X-Ray,Cine-CT,Computerized Tomography, X-Ray,Electron Beam Computed Tomography,Tomodensitometry,Tomography, Transmission Computed,X-Ray Tomography, Computed,CAT Scan, X Ray,CT X Ray,Computed Tomography, X-Ray,Computed X Ray Tomography,Computerized Tomography, X Ray,Electron Beam Tomography,Tomography, X Ray Computed,Tomography, X-Ray Computer Assisted,Tomography, X-Ray Computerized,Tomography, X-Ray Computerized Axial,Tomography, Xray Computed,X Ray Computerized Tomography,X Ray Tomography, Computed,X-Ray Computer Assisted Tomography,X-Ray Computerized Axial Tomography,Beam Tomography, Electron,CAT Scans, X-Ray,CT Scan, X Ray,CT Scans, X-Ray,CT X Rays,Cine CT,Computed Tomography, Transmission,Computed Tomography, X Ray,Computed Tomography, Xray,Computed X-Ray Tomography,Scan, X-Ray CAT,Scan, X-Ray CT,Scans, X-Ray CAT,Scans, X-Ray CT,Tomographies, Computed X-Ray,Tomography, Computed X-Ray,Tomography, Electron Beam,Tomography, X Ray Computer Assisted,Tomography, X Ray Computerized,Tomography, X Ray Computerized Axial,Transmission Computed Tomography,X Ray Computer Assisted Tomography,X Ray Computerized Axial Tomography,X Ray, CT,X Rays, CT,X-Ray CAT Scan,X-Ray CAT Scans,X-Ray CT Scan,X-Ray CT Scans,X-Ray Computed Tomography,X-Ray Computerized Tomography,Xray Computed Tomography
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F

Related Publications

Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
July 2024, Clinical nuclear medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
September 2012, Clinical nuclear medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
January 2013, Clinical imaging,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
November 2015, Clinical nuclear medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
January 2015, Asia Oceania journal of nuclear medicine & biology,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
May 2007, The Journal of reproductive medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
August 2019, Clinical nuclear medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
January 2016, Clinical nuclear medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
November 2020, Clinical nuclear medicine,
Yasuhiro Maruoka, and Koichiro Abe, and Shingo Baba, and Takuro Isoda, and Yoshio Matsuo, and Yuichiro Kubo, and Shinji Ogawa, and Tokujiro Yano, and Masayuki Sasaki, and Hiroshi Honda
February 2014, Clinical nuclear medicine,
Copied contents to your clipboard!